Welcome! If you have any pricing inquiries, please don't hesitate to reach out to us using the form on the left side. We'll respond to you promptly.
CD Formulation specializes in harnessing the power of innovative structures to revolutionize drug delivery, diagnostics, and biotechnology. Leveraging our expertise in protein science and nanomedicine, we design versatile cage structures through rational molecular engineering and self-assembly techniques.
As natural biomaterials, caged protein nanoparticles offer excellent biocompatibility and biodegradability. They get their name from the "caged" structure formed through the self-assembly of large numbers of weak protein-protein interactions. Researchers have developed various caged nanoparticles using proteins like ferritin and viral capsids that assemble into spherical cages with interior cores or wells capable of storing targeting ligands, imaging agents, drugs or genes.
Schematic diagram of drug loading/release and biological effects of caged protein nanoparticles (Molino N.M.; Wang S.W. 2014)
|
|
Adenovirus Rotavirus HIV-1 SHIV Hepatitis B virus Murine polyomavirus Avian sarcoma leukosis virus Cowpea chlorotic mottle virus Cowpea mosaic virus Cucumber mosaic virus Red clover necrotic mosaic virus Hibiscus ringspot virus JC polyomavirus MS2 bacteriophage |
Ferritin
Heat shock protein |
Our protein engineers and biophysical scientists will design novel cage protein monomers and optimize assembly conditions to build customized nanoparticles with the ideal size, shape and internal structure for efficiently loading various nucleic acid constructs.
We recombinantly express the cage protein monomers in bacteria, insect or mammalian cell systems using molecular cloning techniques. This produces high yields of purified protein building blocks.
We carefully optimize reaction parameters such as pH, temperature and protein concentration, and the purified proteins undergo controlled buffer conditions to promote multimerization into cage structures through non-covalent interactions.
Size exclusion or density gradient centrifugation techniques will be used by us to separate monodisperse cage nanoparticles from misassembled proteins and other impurities.
We apply site-specific mutagenesis and conjugation chemistry to introduce functional ligands such as PEG chains, targeting antibodies/peptides and endosomal escape domains to the particle surface to enhance biocompatibility, prolonged circulation and intracellular trafficking.
We perform extensive multidisciplinary analyses including dynamic light scattering, atomic force microscopy, gel electrophoresis and microscopy to validate particle size, structure, nucleic acid association, stability and release kinetics.
Our custom caged protein nanoparticles efficiently deliver nucleic acids (such as DNA or RNA) to target cells, facilitating gene editing, gene silencing, and gene expression regulation for therapeutic purposes.
Our development services can also be applied to the targeted delivery of immunotherapeutic agents, including antibodies, cytokines or small molecules, enhancing their stability and facilitating precise immunotherapeutic intervention.
We can help customers design caged protein nanoparticles as imaging agents or carriers of diagnostic markers to achieve precise detection and imaging of specific cells or tissues.
We delve into the use of caged protein nanoparticles in biotechnological research, including enzyme immobilization and biocatalysis.
If you seek to advance your field through the application of biosafe, versatile protein-based nanotechnologies, contact us to discuss how we can create customized caged protein nanoparticles specifically addressing your needs!
References